Double Medical Technology Inc
SZSE:002901

Watchlist Manager
Double Medical Technology Inc Logo
Double Medical Technology Inc
SZSE:002901
Watchlist
Price: 34.4 CNY Market Closed
Market Cap: 14.2B CNY
Have any thoughts about
Double Medical Technology Inc?
Write Note

Double Medical Technology Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Double Medical Technology Inc
Interest Income Expense Peer Comparison

Comparables:
A
688617
J
002223
300760
J
300529
688271

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Double Medical Technology Inc
SZSE:002901
Interest Income Expense
ÂĄ29.7m
CAGR 3-Years
14%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Interest Income Expense
ÂĄ18m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Interest Income Expense
ÂĄ318.3m
CAGR 3-Years
N/A
CAGR 5-Years
47%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Interest Income Expense
ÂĄ804m
CAGR 3-Years
N/A
CAGR 5-Years
23%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Interest Income Expense
ÂĄ21.9m
CAGR 3-Years
-22%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Interest Income Expense
ÂĄ257.2m
CAGR 3-Years
190%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Double Medical Technology Inc's Interest Income Expense?
Interest Income Expense
29.7m CNY

Based on the financial report for Jun 30, 2024, Double Medical Technology Inc's Interest Income Expense amounts to 29.7m CNY.

What is Double Medical Technology Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-4%

Over the last year, the Interest Income Expense growth was -20%. The average annual Interest Income Expense growth rates for Double Medical Technology Inc have been 14% over the past three years , -4% over the past five years .

Back to Top